Select language:  
1800 620 420
Close menu

mononclonal antibodies

Highly specific antibodies produced by cells grown in the laboratory. Current research is investigating their clinical application for targeted delivery of drugs to leukaemia cells. Some antibodies against lymphoma have been developed which are directly toxic to lymphoma cells.

< Back to glossary index

Last updated on April 17th, 2023

Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.